Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Melanoma and MYC[original query] |
|---|
| Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. The American journal of pathology 2011 Mar 178 (3): 1395-402. Shibata Tatsuhiro, Kokubu Akiko, Miyamoto Masashi, Sasajima Yuko, Yamazaki Nao |
| The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget 2017 Jan . Fancello Laura, Kampen Kim R, Hofman Isabel Jf, Verbeeck Jelle, De Keersmaecker K |
| Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma. Scientific reports 2019 Dec 9 (1): 19235. Kim Yong Joon, Park Seo Jin, Maeng Kyung Joo, Lee Sung Chul, Lee Christopher Seungk |
| Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 2020 8 12 (9): . Hilke Franz J, Sinnberg Tobias, Gschwind Axel, Niessner Heike, Demidov German, Amaral Teresa, Ossowski Stephan, Bonzheim Irina, Röcken Martin, Riess Olaf, Garbe Claus, Schroeder Christopher, Forschner Andr |
| Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies. Cancer reports (Hoboken, N.J.) 2020 Jul e1267. Naderi A |
| Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers. Asian Pacific journal of cancer prevention : APJCP 2020 11 21 (11): 3199-3209. Qureshi Muhammad Asif, Khan Saeed, Tauheed Muhammad Sohaib, Syed Sofia Ali, Ujjan Ikram Din, Lail Amanullah, Sharafat Shahe |
| Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy. Targeted oncology 2020 1 15 (1): 101-113. Olbryt Magdalena, Pig?owski Wojciech, Rajczykowski Marcin, Pfeifer Aleksandra, Student Sebastian, Fiszer-Kierzkowska An |
| Expanding the phenotype of E318K (c.952G?>?A) MITF germline mutation carriers: case series and review of the literature. Hereditary cancer in clinical practice 2021 Jul 19 (1): 32. Oliveira Leandro Jonata Carvalho, Gongora Aline Bobato Lara, Lima Fabiola Ambrosio Silveira, Canedo Felipe Sales Nogueira Amorim, Quirino Carla Vanessa, Pisani Janina Pontes, Achatz Maria Isabel, Rossi Benedito Mau |
| Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment. ESMO open 2021 1 6 (1): 100002. Byeon S, Cho H J, Jang K-T, Kwon M, Lee J, Lee J, Kim S |
| Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy. Scientific reports 2022 Jun 12 (1): 9559. Huang Fuxue, Li Jingjing, Wen Xizhi, Zhu Baoyan, Liu Wei, Wang Jiuhong, Jiang Hang, Ding Ya, Li Dandan, Zhang Xiaos |
| Molecular profiling of primary uveal melanoma: results of a Polish cohort. Melanoma research 2023 1 33 (2): 104-115. Kowalik Artur, Karpinski Pawel, Markiewicz Anna, Orlowska-Heitzman Jolanta, Romanowska-Dixon Bozena, Donizy Piotr, Hoang Mai |
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. International journal of clinical oncology 2024 9 . Tokimasa Hida, Junji Kato, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| Genetic Analysis of Melanoma Types Using Japanese Genomic Database. The Laryngoscope 2024 8 . Hayato Matsumoto, Hiromi Nagano, Takayuki Kyutoku, Masaru Yamashi |
| Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort. Oral oncology 2024 4 152 106807. Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hi |
- Page last reviewed:Feb 1, 2024
- Content source: